| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
6.64(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $16.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
157,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,415,734 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bilbrey John P |
|
– • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
39,857 |
|
- |
|
| Anand Kapila K |
|
– • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
46,116 |
|
- |
|
| Bilbrey John P |
|
– • – |
2022-11-11 |
4 |
B |
$13.24 |
$99,267 |
I/I |
7,500 |
41,722 |
0.01 |
-33% |
|
| De Brabander Ellen |
SEE REMARKS |
• – – |
2022-11-01 |
4 |
D |
$13.28 |
$149,998 |
D/D |
(11,295) |
48,836 |
|
- |
|
| Modi Rajeev A. |
SEE REMARKS |
• – – |
2022-09-09 |
4 |
B |
$14.90 |
$99,830 |
D/D |
6,700 |
41,157 |
0.01 |
-12% |
|
| Herendeen Paul |
|
– • – |
2022-09-09 |
4 |
B |
$15.03 |
$150,250 |
D/D |
10,000 |
17,307 |
0.01 |
-12% |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2022-09-09 |
4 |
B |
$14.54 |
$436,146 |
I/I |
30,000 |
30,000 |
0.01 |
-12% |
|
| Hoover R David |
|
– • – |
2022-09-09 |
4 |
B |
$15.18 |
$303,614 |
I/I |
20,000 |
145,000 |
0.01 |
-12% |
|
| Kirberger Marcela A. |
SEE REMARKS |
• – – |
2022-07-01 |
4 |
D |
$20.62 |
$38,518 |
D/D |
(1,868) |
17,287 |
|
- |
|
| Correia De Simas Jose Manuel |
SEE REMARKS |
• – – |
2022-07-01 |
4 |
D |
$20.62 |
$44,787 |
D/D |
(2,172) |
19,607 |
|
- |
|
| Hoover R David |
|
– • – |
2022-05-20 |
4 |
B |
$23.33 |
$233,269 |
I/I |
10,000 |
125,000 |
0.01 |
-49% |
|
| Bilbrey John P |
|
– • – |
2022-05-11 |
4 |
B |
$22.03 |
$220,284 |
I/I |
10,000 |
34,222 |
0.01 |
-34% |
|
| Modi Rajeev A. |
SEE REMARKS |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
34,457 |
34,457 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2022-03-05 |
4 |
D |
$27.95 |
$298,730 |
D/D |
(10,688) |
752,986 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-03-02 |
4 |
D |
$29.00 |
$8,149 |
D/D |
(281) |
19,318 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2022-03-02 |
4 |
D |
$29.00 |
$27,869 |
D/D |
(961) |
92,358 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2022-03-02 |
4 |
D |
$29.00 |
$25,346 |
D/D |
(874) |
94,643 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2022-03-02 |
4 |
D |
$29.00 |
$61,915 |
D/D |
(2,135) |
119,949 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2022-03-02 |
4 |
D |
$29.00 |
$36,279 |
D/D |
(1,251) |
82,941 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2022-03-02 |
4 |
D |
$29.00 |
$257,491 |
D/D |
(8,879) |
763,674 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2022-03-02 |
4 |
B |
$29.00 |
$145,000 |
I/I |
5,000 |
115,000 |
2.1 |
-31% |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$11,084 |
D/D |
(383) |
19,599 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,955 |
19,982 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
D |
$28.94 |
$52,092 |
D/D |
(1,800) |
93,319 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,341 |
95,119 |
|
- |
|
390 Records found
|
|
Page 6 of 16 |
|
|
0.26 (1.96%) 
